(Q48944712)

17 February 2018

title

Altered hypothalamic and sympathetic responses to hypoglycaemia in familial obesity. (English)

1 reference

17 February 2018

0 references

1 reference

R T Jung

1

1 reference

17 February 2018

R G Campbell

series ordinal

2

1 reference

17 February 2018

W P James

series ordinal

3

1 reference

17 February 2018

B A Callingham

series ordinal

4

1 reference

17 February 2018

language of work or name

English

0 references

publication date

1 May 1982

1 reference

17 February 2018

published in

The Lancet

1 reference

17 February 2018

volume

1

1 reference

17 February 2018

issue

8280

1 reference

17 February 2018

page(s)

1043-1046

1 reference

17 February 2018

Reduced thermogenesis in obesity

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2882%2992100-6

7 January 2021

Postprandial thermogenesis in obesity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2882%2992100-6

7 January 2021

Thermoregulation and non-shivering thermogenesis in the genetically obese (ob/ob) mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2882%2992100-6

7 January 2021

Serum growth hormone and prolactin during and after the development of the obese-hyperglycemic syndrome in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2882%2992100-6

7 January 2021

Impaired hypothalamic control of prolactin secretion in massive obesity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2882%2992100-6

7 January 2021

Persistence of defective hypothalamic control of prolactin secretion in some obese women after weight reduction.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2882%2992100-6

7 January 2021

https://api.crossref.org/works/10.1016%2FS0140-6736%2882%2992100-6

1 reference

7 January 2021

Effect of weight reduction, triiodothyronine, and diethylstilbestrol on growth hormone in obesity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2882%2992100-6

7 January 2021

Impaired prolactin secretion in obese patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2882%2992100-6

7 January 2021

Inducible metabolic abnormalities during development of obesity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2882%2992100-6

7 January 2021

Effect of Weight Loss on the Growth Hormone Response to Arginine Infusion in Obesity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2882%2992100-6

7 January 2021

Growth hormone response in the thinned obese.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2882%2992100-6

7 January 2021

Plasma norepinephrine and epinephrine in untreated diabetics, during fasting and after insulin administration.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2882%2992100-6

7 January 2021

Stimulation of Human Prolactin Secretion by Intravenous Infusion of L-Tryptophan

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2882%2992100-6

7 January 2021

Suppression of sympathetic nervous system during fasting.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2882%2992100-6

7 January 2021

10.1016/S0140-6736(82)92100-6

Identifiers

DOI

1 reference

17 February 2018

1 reference

17 February 2018